The only way it makes sense to do a larger trial is if there's a chance the statistical signifcance goes down with a larger population. Meaning the secondary endpoint results of the P2 trial was a fluke. Obviously I don't believe that given the MOA described by Dr. P and verified by his meticulous labwork. If the EFF-DA wants to EFF aroujd, EFF them.